The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
A man who launched a savage attack on his partner and another on the mother of his children minutes later has admitted two counts of murder.
The pilot of the missing MH370 plane plotted a course to the southern Indian Ocean on a home flight simulator, investigators have said.
Joe Campbell said he wanted to adopt Kiran Sheikh but was told he couldn't because he wasn't married.